As of Oct 26
| -0.45 / -13.24%|
The 2 analysts offering 12-month price forecasts for OHR Pharmaceutical Inc have a median target of 9.00, with a high estimate of 13.00 and a low estimate of 5.00. The median estimate represents a +205.08% increase from the last price of 2.95.
The current consensus among 3 polled investment analysts is to Buy stock in OHR Pharmaceutical Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.